Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee

Clinical trial NCT04433572 · RECRUITING

Trial details

NCT number: NCT04433572
Sponsor: Mercator MedSystems, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Peripheral Artery Disease Critical Limb Ischemia

Start date: 2025-07-30
Primary completion: 2028-02-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.